Claims-Based Algorithm to Identify Pre-Exposure Prophylaxis Indications for Tenofovir Disoproxil Fumarate and Emtricitabine Prescriptions (2012-2014): Validation Study

JMIR Form Res. 2024 Nov 4:8:e55614. doi: 10.2196/55614.

Abstract

Background: To monitor the use of tenofovir disoproxil fumarate and emtricitabine (TDF/FTC) and related medicines for pre-exposure prophylaxis (PrEP) as HIV prevention using commercial pharmacy data, it is necessary to determine whether TDF/FTC prescriptions are used for PrEP or for some other clinical indication.

Objective: This study aimed to validate an algorithm to distinguish the use of TDF/FTC for HIV prevention or infectious disease treatment.

Methods: An algorithm was developed to identify whether TDF/FTC prescriptions were for PrEP or for other indications from large-scale administrative databases. The algorithm identifies TDF/FTC prescriptions and then excludes patients with International Classification of Diseases (ICD)-9 diagnostic codes, medications, or procedures that suggest indications other than for PrEP (eg, documentation of HIV infection, chronic hepatitis B, or use of TDF/FTC for postexposure prophylaxis). For evaluation, we collected data by clinician assessment of medical records for patients with TDF/FTC prescriptions and compared the assessed indication identified by the clinician review with the assessed indication identified by the algorithm. The algorithm was then applied and evaluated in a large, urban, community-based sexual health clinic.

Results: The PrEP algorithm demonstrated high sensitivity and moderate specificity (99.6% and 49.6%) in the electronic medical record database and high sensitivity and specificity (99% and 87%) in data from the urban community health clinic.

Conclusions: The PrEP algorithm classified the indication for PrEP in most patients treated with TDF/FTC with sufficient accuracy to be useful for surveillance purposes. The methods described can serve as a basis for developing a robust and evolving case definition for antiretroviral prescriptions for HIV prevention purposes.

Keywords: EHR; EMR; HIV; PrEP; algorithm; classification; drug; electronic health record; electronic medical record; medication; monotherapy; pharmaceutical; pharmacology; pharmacotherapy; pre-exposure prophylaxis; prevention.

Publication types

  • Validation Study

MeSH terms

  • Adult
  • Algorithms*
  • Anti-HIV Agents / administration & dosage
  • Anti-HIV Agents / therapeutic use
  • Drug Prescriptions / statistics & numerical data
  • Emtricitabine* / administration & dosage
  • Emtricitabine* / therapeutic use
  • Female
  • HIV Infections* / drug therapy
  • HIV Infections* / prevention & control
  • Humans
  • Male
  • Middle Aged
  • Pre-Exposure Prophylaxis* / methods
  • Tenofovir* / administration & dosage
  • Tenofovir* / therapeutic use

Substances

  • Tenofovir
  • Emtricitabine
  • Anti-HIV Agents